SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility as traders balance technical momentum against geopolitical uncertainty surrounding regional conflicts and pending diplomatic negotiations. Community sentiment remains sharply divided, with bulls pointing to robust institutional inflows and long-term scarcity as catalysts for a squeeze, while bears highlight risks from potential regulatory shifts and macroeconomic pressures.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is surging as traders grow optimistic about progress on the Clarity Act, fueling speculation that clearer regulatory guidelines will catalyze institutional adoption and expand the company's role as a leading digital asset exchange. The community is actively debating the stock's correlation with Bitcoin's recent price action, with many using the current volatility to position themselves for a potential breakout toward prior resistance levels.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing an intense, parabolic short squeeze driven by an extreme supply-demand imbalance and highly concentrated institutional ownership. While the community is actively debating the sustainability of the stock's massive rally and the potential for regulatory or corporate intervention, retail traders are focused on the extreme volatility, high option premiums, and the ongoing battle between trapped short sellers and aggressive bulls.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense social media debate as investors weigh the company's aggressive and ongoing Bitcoin accumulation strategy against concerns regarding debt-funded dilution. Market participants are closely watching the stock's role as a levered proxy for Bitcoin, with sentiment split between those anticipating a major breakout tied to BTC price appreciation and others warning of unsustainable leverage and potential downside risks.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is capturing significant investor attention as the community anticipates critical upcoming prostate cancer data presentations at the American Urological Association conference. Shareholders are expressing strong bullish conviction, citing the company's platform potential and pipeline progress as key drivers for long-term value despite recent share price volatility.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging following the release of positive registrational trial data for its CAR T-cell therapy, miv-cel, in treating Stiff Person Syndrome, with the company announcing plans for a BLA submission in early 2026. The community is buzzing over the therapy's potential as a 'first-in-class' treatment for autoimmune diseases, fueling speculation regarding a potential buyout or partnership given the firm's robust clinical results and large-scale manufacturing advancements.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is currently attracting attention as a leveraged Bitcoin play, with investors closely watching the company's significant BTC holdings and the potential impact of its new digital credit ETF. The community is actively debating the company's long-term valuation and management strategies, balancing bullish sentiment regarding Bitcoin's future against concerns over past equity dilution and share performance.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch (IMG) is gaining traction as community members highlight its passive Solana reward mechanism, which distributes earnings every six hours without requiring traditional staking. Supporters are framing the asset as a resilient, "battle-tested" play, focusing on long-term project building and a deflationary model that remains a key point of discussion for those looking to capitalize on automated on-chain rewards.

Dogelon Mars

Dogelon Mars continues to trend as investors speculate on potential synergies with Elon Musk's ventures and track the coin's historical meme status. Community sentiment remains polarized, with many holders focused on long-term accumulation and anticipation of future exchange listings, while others express frustration over stagnant price action and the lack of utility.

Spark is an onchain capital allocator, with $3.86B deployed across DeFi, CeFi, and RWA. It unlocks capital efficiency at scale, auto-balancing allocations based on market conditions while maintaining a conservative risk profile. Spark was created to solve DeFi’s core inefficiencies: fragmented liquidity, unstable yields, and idle stablecoin capital. It acts as a two-sided capital allocator—borrowing from Sky’s $6.5B+ reserves and deploying across DeFi, CeFi, and RWAs to provide deep, consistent liquidity. This yield is packaged into products like sUSDS and sUSDC, offering users programmable, fee-free income. Rather than competing with protocols, Spark powers them as the liquidity and yield infrastructure for onchain finance.  Access to Deep, Scalable Liquidity: Spark taps into Sky’s $6.5B+ stablecoin reserves, enabling large-scale capital deployment across DeFi, CeFi, and RWAs. User-Friendly Yield Products: Yield is delivered through stablecoins like sUSDS and sUSDC—fully composable, fee-free, and available across chains.  SparkLend: A stablecoin lending market. Unlike other lending protocols where rates fluctuate based on utilization or loan size, SparkLend offers governance-defined rates that do not vary based on those factors. This is made possible by Spark’s Liquidity Layer (SLL), which supplies consistent stablecoin liquidity to the protocol.  Spark Savings: A product for earning yield on stablecoins like USDC, and USDS (and soon, USDT) by converting them into yield-bearing sUSDS or sUSDC. These yield tokens are composable with other DeFi protocols, making it easy to put capital to work while maintaining exposure to onchain yield at a competitive risk-adjusted rate.  Spark Liquidity Layer (SLL): A backend capital allocator that routes liquidity to other protocols like Aave, Morpho, and even RWAs (e.g., BlackRock’s BUIDL). One of the most important SLL deployments on Base is the Spark USDC Morpho Vault, which currently supplies $95M USDC, making it the largest liquidity provider to the Coinbase app integration on Base. This vault plays a key role in mitigating rate volatility for borrowers and demonstrates how SLL enhances liquidity conditions across DeFi.  Existing Products: Spark's total TVL is currently $7.9B, split between SparkLend and the Spark Liquidity Layer (SLL). You can find real-time details and breakdowns here: https://defillama.com/protocol/spark#information  Spark in DeFiLlama, https://defillama.com/protocol/spark#information  SparkLend is one of the largest lending protocols in DeFi. It offers deep liquidity and governance-defined rates, providing borrowers with transparent conditions.  Spark Savings is live on Ethereum mainnet, Base, Optimism, Arbitrum, Unichain, and Gnosis, offering vaults for both USDS and USDC.  The Spark Liquidity Layer actively deploys capital across protocols on multiple chains, including Ethereum mainnet, Base, and Arbitrum.  SLL allocations in real-time, https://data.spark.fi/spark-liquidity-layer

Spark

Spark is gaining significant community traction as users highlight its utility in providing native yield for stablecoins across multiple blockchain ecosystems, including recent expansion onto Optimism and Unichain. Investors are actively discussing the token's growth potential and institutional-grade infrastructure, with many monitoring volume spikes and technical breakout patterns.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BIIB Inks Deal to Acquire Rights to Felzartamab in China, Stock Up

Biogen gains after securing Greater China rights to felzartamab, giving it worldwide control as phase III studies advance in immune diseases.

Align Technology's Q1 Earnings on Deck: Here's What to Expect

ALGN's Q1 report looms with revenues seen rising 4.3% and EPS up 6.1%, as Invisalign demand and iTero adoption drive growth trends.

HSBC Predicts Biogen's Q1 Earnings (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB - Free Report) - Investment analysts at HSBC issued their Q1 2026 earnings per share estimates for shares of Biogen in a research note issued to investors on Friday, April...

Mirae Asset Global Investments Co. Ltd. Decreases Position in Biogen Inc. $BIIB

Mirae Asset Global Investments Co. Ltd. cut its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 47.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned...

Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. - APLS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Apellis Pharmaceuticals, Inc. (NasdaqGS: APLS...

Edwards Lifesciences' Q1 Earnings on Deck: Here's What to Expect

EW heads into Q1 earnings with TAVR strength, rising estimates and momentum in mitral and tricuspid therapies shaping expectations.

Buy 5 Non-Tech Wide Moat Stocks to Strengthen Your Portfolio

BIIB, LMT, NOC, MA and MTD are five non-tech wide moat picks as durable advantages, defense demand, and digital payments growth position these stocks for resilient returns.

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Microsoft, Amazon, Ulta Beauty, Okta, Biogen, Meta & more

Here are the biggest calls on Wall Street on Monday...

Zurcher Kantonalbank Zurich Cantonalbank Buys 104,038 Shares of Biogen Inc. $BIIB

Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 29.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 452,442 shares of the biotechnology company's stock after pur...

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region PR Newswire CAMBRIDGE, Mass. and HANGZHOU, China, April 20, 2026 With this transaction, Biogen now owns...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$3.00	--	--	N/A
Q4 '25	$1.63	$1.99	22.45%	BEAT
Q3 '25	$3.88	$4.81	23.89%	BEAT
Q2 '25	$3.90	$5.47	40.38%	BEAT
Q1 '25	$2.90	$3.02	4.16%	BEAT

BIIB
Biogen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest BIIB News

BIIBBiogen Inc